Propofol for gastrointestinal endoscopy

Toshihiro Nishizawa, Hidekazu Suzuki

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)

Abstract

Most gastrointestinal endoscopic procedures are now performed with sedation. Moderate sedation using benzodiazepines and opioids continues to be widely used, but propofol sedation is becoming more popular because its unique pharmacokinetic properties make endoscopy almost painless, with a very predictable and rapid recovery process. There is controversy as to whether propofol should be administered only by anesthesia professionals. According to published values, endoscopist-directed propofol has a lower mortality rate than endoscopist-delivered benzodiazepines and opioids, and a comparable rate to general anesthesia by anesthesiologists. Rapid recovery has a major impact on patient satisfaction, post-procedure education and the general flow of the endoscopy unit. According to estimates, the absolute economic benefit of endoscopist-directed propofol implementation in a screening setting is probably substantial, with 10-year savings of $3.2 billion in the USA. Guidelines concerning the use of propofol emphasize the need for adequate training and certification in sedation by non-anesthetists.

Original languageEnglish
Pages (from-to)801-805
Number of pages5
JournalUnited European Gastroenterology Journal
Volume6
Issue number6
DOIs
Publication statusPublished - 2018 Jul 1

Keywords

  • Propofol
  • gastrointestinal endoscopy
  • sedative agents

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Propofol for gastrointestinal endoscopy'. Together they form a unique fingerprint.

Cite this